Skip to main content
Quest Diagnostics

Two Additional Cases of GM3 Synthase Deficiency in Non-amish Patients

ASHG 2023

American  Society of Human Genetics

Washington, DC, Nov 1-5, 2023

Poster presentation: Two additional cases of GM3 synthase deficiency in non-Amish patients

Authors: Muskett J, Chambers JM, Franchi M, Trapane P, Platt MY

Specialty: Geneteics, Neurology

Related content

Publication
Genetic testing for the epilepsies: A systematic review
Conference Presentation
A Web-Based Educational Program to Support the Updated ACMG/ClinGen Technical Standards for Constitutional Copy Number Variant Classification
Conference Presentation
Characterization of CNVs Identified by Genetic Testing of Epilepsy
Audio Podcast
The power of laboratory analytics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.